Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children’s Research Hospital and at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results of this study appear today in the journal Science Translational Medicine.
The study involved five males with X-linked severe combined immunodeficiency disease (SCID-X1), also known as “Bubble Boy” disease, who were all treated at NIAID. This inherited disorder involves a mutation in the IL2RG gene that affects males and occurs in 1 of every 50,000 to 100,000 live births, leaving them with little to no immune protection.
To view the multimedia release go to:
http://www.multivu.com/players/English/7808651-st-jude-gene-therapy-results/
GB Sciences, Inc. (OTCQB: GBLX) announces the success of its first annual, “Innovation in Medical Cannabis Therapies” (IMCT) Symposium, held on Friday, November 9th at the “Keep Memory Alive” Event Center at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada. Throughout the day’s program, there was an emerging sense of heightened responsibility on the part of the cannabis industry to better address medical cannabis patients' needs through research and development of medical cannabis products that are better standardized, more easily-dosed, and made more widely-available to cannabis patients at a fair price.
To view the multimedia release go to:
https://www.multivu.com/players/English/8308958-gb-sciences-2018-medical-cannabis-therapies-symposium/
Having lost his mother to the disease, singer, songwriter Gavin DeGraw knows firsthand how devastating pancreatic cancer is for patients and their families. Gavin is turning his grief into action by helping the Lustgarten Foundation raise awareness by encouraging people to get involved with the Foundation.
“My mother didn’t make it and unfortunately right now that’s a common story. But it doesn’t have to be the story permanently,” DeGraw said. “By funding research, the Lustgarten Foundation is going to change the course of this disease. I encourage everyone to get involved in some way – join a walk or make a donation.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213753-lustgarten-foundation-pancreatic-cancer-awareness/
1st question: How can you make oral s*x less painful in your jaw?
The pain in your jaw when perform blowj*b could be caused by a TMJ disorder and you may need to seek professional help. Then you need to open up and elaborate the problem to your doctor. But of course, you don’t want to get in trouble by sucking your own doctor’s c*ck or even involve in a three-way situation by inviting in a medical staff, like a nurse perhaps.
Also you might want to change the position on the way you blow your partner’s organ. You may also want to relax when you are actually doing it.
2nd question: Does size really matter?
Yes. Size really matters. Some other things matter so much more than a few others out there. But what’s more important is that you should utilize what you have in a professional way. And you should always work things out to get them connected. You might also want to consider that not everybody fits anybody else.
The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in New York; MD Anderson Cancer Center in Houston; Fondazione Centro San Raffaele in Milan; and South Australian Health & Medical Research Institute in Adelaide.
This $40.3 million investment, comprised of 75 new research grants in LLS’s portfolio of 300 projects, will fund a diverse array of research to find better treatments and cures for patients with leukemia, lymphoma, myeloma and other blood cancers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554855-lls-invests-millions-new-research-treatment-cures/
Las Vegas Sands Corp. (NYSE: LVS), and social enterprise Clean the World announced today a first-of-its-kind service in Las Vegas to help homeless people. The Sands Cares Fresh Start Mobile Showers Powered by Clean the World is a traveling hygiene unit that visits locations serving the homeless to provide showers, hygiene supplies and other resources.
LVS contributed more than $200,000 to Sands Cares Fresh Start Mobile Showers, which was unveiled in Las Vegas on July 27, and will offer approximately 250 showers per week. To reach people in need, Clean the World and Las Vegas Sands have partnered with four Las Vegas organizations to offer the service through their homeless community outreach efforts, including WestCare, CARE Complex, Nevada Homeless Alliance and the Nevada Partnership for Homeless Youth. Sands Cares Fresh Start Mobile Showers will provide hygiene services at a partner organization one day each week, where clients can also receive access to a wide array of support, such as emergency shelter, food and clothing supplies, medical care and detoxification services.
To view the multimedia release go to:
https://www.multivu.com/players/English/8061851-las-vegas-sands-clean-the-world-fresh-start-mobile-showers/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
A brief Introduction to the fact that we can use the subconscious mind for healing.
Self improvement follows!
Psycho-neuro-immunology has been proved by medical scientists and is a specific self-improvement technique.
It is the ability to focus the mind in the meditation state then using guided imagery and visualization there is an increase in the T4 cell count which is the fighting cell in the immune system.
This is the deliberate use of the subconscious mind.
Introducing the fact that healing is aided by deliberate use of the subconscious.
Not only will you feel better but real Self Improvement is achieved!
Psycho-neuro-immunology has been proved by medical scientists and is a specific self-improvement technique.
To achieve increasing the fighting cell (T4) in the immune system you use guided imagery and visualization.
The end result is using the subconscious mind deliberately.
A brief Introduction to the fact that we can use the subconscious mind for healing.
Not only will you feel better but real Self Improvement is achieved!
Psycho-neuro-immunology has been proved by medical scientists and is a specific self-improvement technique.
To achieve increasing the fighting cell (T4) in the immune system you use guided imagery and visualization.
This is the deliberate use of the subconscious mind.
